Target intelligence / Profile preview

Ventrolateral geniculate nucleus enkephalinergic neuron

Molecular classification
Other (neuronal cell type), Neuropeptide-expressing neuron
01

Overview

The **ventrolateral geniculate nucleus (vLGN)** is a subdivision of the thalamus found in rodents and other mammals that receives input from retinal ganglion cells and projects primarily to subcortical sensorimotor structures rather than directly relaying information to the cortex[2][5][6]. Within the vLGN, several types of neurochemically distinct neurons exist—including those expressing **enkephalins**, which are endogenous opioid peptides involved in neuromodulation[1][3][6]. Enkephalinergic neurons in the vLGN participate in circuits regulating non-image-forming visual functions such as circadian rhythm entrainment and visuomotor integration[1][5]. These cells share many properties with similar populations found in adjacent regions like the intergeniculate leaflet (IGL), including expression of GABA and other neuropeptides such as neuropeptide Y[1][3]. While these neurons play important roles at the circuit level—modulating sensory input integration relevant for behavioral state regulation—they do not constitute discrete molecular targets suitable for direct pharmacological intervention under current scientific paradigms. Their function relates more broadly to thalamocortical circuitry underlying vision-linked behaviors and biological timing systems rather than being individually druggable entities.

Other names
vLGN enkephalinergic neuronEnkephalin-expressing neurons of the ventral lateral geniculate nucleus
02

Mechanism of action

Not applicable for this neuronal subtype itself; however, endogenous opioids like enkephalins modulate synaptic transmission via activation of opioid receptors on these and other neurons.

03

Biological functions

Modulation of visual information processingRegulation of circadian rhythmsParticipation in visuomotor responses
04

Disease associations

Other (no direct disease association established; may be involved indirectly in disorders affecting circadian rhythms or visual processing)

Beyond the preview

Go deeper on Ventrolateral geniculate nucleus enkephalinergic neuron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventrolateral geniculate nucleus enkephalinergic neuron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call